CH516558A - Verfahren zur Herstellung neuer Indenopyridinderivate - Google Patents
Verfahren zur Herstellung neuer IndenopyridinderivateInfo
- Publication number
- CH516558A CH516558A CH696769A CH696769A CH516558A CH 516558 A CH516558 A CH 516558A CH 696769 A CH696769 A CH 696769A CH 696769 A CH696769 A CH 696769A CH 516558 A CH516558 A CH 516558A
- Authority
- CH
- Switzerland
- Prior art keywords
- formula
- acid
- hydrogen
- acid addition
- alkyl
- Prior art date
Links
- 239000003814 drug Substances 0.000 title description 3
- 239000002253 acid Substances 0.000 claims abstract description 36
- 150000003839 salts Chemical class 0.000 claims abstract description 21
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 15
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 10
- 229910052794 bromium Inorganic materials 0.000 claims abstract description 5
- 229910052801 chlorine Inorganic materials 0.000 claims abstract description 5
- 229910052731 fluorine Inorganic materials 0.000 claims abstract description 3
- 150000001875 compounds Chemical class 0.000 claims description 38
- 238000000034 method Methods 0.000 claims description 14
- 239000001257 hydrogen Substances 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 238000002360 preparation method Methods 0.000 claims description 5
- PFWJFKBTIBAASX-UHFFFAOYSA-N 9h-indeno[2,1-b]pyridine Chemical class C1=CN=C2CC3=CC=CC=C3C2=C1 PFWJFKBTIBAASX-UHFFFAOYSA-N 0.000 claims description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 4
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 3
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 3
- 239000000460 chlorine Substances 0.000 claims description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 3
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 3
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 2
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 2
- 239000011737 fluorine Substances 0.000 claims description 2
- 239000012458 free base Substances 0.000 claims description 2
- 125000000623 heterocyclic group Chemical group 0.000 claims description 2
- 150000002431 hydrogen Chemical group 0.000 claims description 2
- UINFICGYFFOSMB-UHFFFAOYSA-N propanoate;pyridin-1-ium Chemical compound CCC(O)=O.C1=CC=NC=C1 UINFICGYFFOSMB-UHFFFAOYSA-N 0.000 claims 1
- -1 anti-ulcerous Substances 0.000 abstract description 4
- 150000004820 halides Chemical class 0.000 abstract description 3
- 230000000767 anti-ulcer Effects 0.000 abstract description 2
- 208000001953 Hypotension Diseases 0.000 abstract 1
- 229940124332 anorexigenic agent Drugs 0.000 abstract 1
- 239000002260 anti-inflammatory agent Substances 0.000 abstract 1
- 230000001741 anti-phlogistic effect Effects 0.000 abstract 1
- 239000002220 antihypertensive agent Substances 0.000 abstract 1
- 239000002830 appetite depressant Substances 0.000 abstract 1
- 208000021822 hypotensive Diseases 0.000 abstract 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Substances C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 abstract 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 14
- 238000006243 chemical reaction Methods 0.000 description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 150000007513 acids Chemical class 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 5
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Substances [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- 241000124008 Mammalia Species 0.000 description 4
- 230000037396 body weight Effects 0.000 description 4
- 238000009835 boiling Methods 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- 239000012730 sustained-release form Substances 0.000 description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- 150000001649 bromium compounds Chemical class 0.000 description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 150000001805 chlorine compounds Chemical class 0.000 description 3
- 238000000354 decomposition reaction Methods 0.000 description 3
- 230000008030 elimination Effects 0.000 description 3
- 238000003379 elimination reaction Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 150000004694 iodide salts Chemical class 0.000 description 3
- 239000000155 melt Substances 0.000 description 3
- 150000004702 methyl esters Chemical class 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 230000018044 dehydration Effects 0.000 description 2
- 238000006297 dehydration reaction Methods 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 2
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 2
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 2
- 150000002440 hydroxy compounds Chemical class 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- XTEGVFVZDVNBPF-UHFFFAOYSA-N naphthalene-1,5-disulfonic acid Chemical compound C1=CC=C2C(S(=O)(=O)O)=CC=CC2=C1S(O)(=O)=O XTEGVFVZDVNBPF-UHFFFAOYSA-N 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 125000006239 protecting group Chemical group 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- ZEVIVLCBODXZAW-UHFFFAOYSA-N 2,3,4,4a,5,9b-hexahydro-1h-indeno[1,2-c]pyridin-5-ol Chemical compound C12=CC=CC=C2C(O)C2C1CNCC2 ZEVIVLCBODXZAW-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- WZFUQSJFWNHZHM-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC(=O)N1CC2=C(CC1)NN=N2 WZFUQSJFWNHZHM-UHFFFAOYSA-N 0.000 description 1
- BQTJMKIHKULPCZ-UHFFFAOYSA-N 2H-indene Chemical compound C1=CC=CC2=CCC=C21 BQTJMKIHKULPCZ-UHFFFAOYSA-N 0.000 description 1
- IYOIBZYIRXERTL-UHFFFAOYSA-N 3-pyridin-2-ylpropanamide Chemical compound NC(=O)CCC1=CC=CC=N1 IYOIBZYIRXERTL-UHFFFAOYSA-N 0.000 description 1
- CONKBQPVFMXDOV-QHCPKHFHSA-N 6-[(5S)-5-[[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]methyl]-2-oxo-1,3-oxazolidin-3-yl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C[C@H]1CN(C(O1)=O)C1=CC2=C(NC(O2)=O)C=C1 CONKBQPVFMXDOV-QHCPKHFHSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 238000005727 Friedel-Crafts reaction Methods 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 1
- 150000008041 alkali metal carbonates Chemical class 0.000 description 1
- 125000005431 alkyl carboxamide group Chemical group 0.000 description 1
- 230000002891 anorexigenic effect Effects 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 229940092714 benzenesulfonic acid Drugs 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- AOGYCOYQMAVAFD-UHFFFAOYSA-N chlorocarbonic acid Chemical compound OC(Cl)=O AOGYCOYQMAVAFD-UHFFFAOYSA-N 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229910000042 hydrogen bromide Inorganic materials 0.000 description 1
- 229910000043 hydrogen iodide Inorganic materials 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 150000002681 magnesium compounds Chemical class 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 229960002895 phenylbutazone Drugs 0.000 description 1
- VYMDGNCVAMGZFE-UHFFFAOYSA-N phenylbutazonum Chemical compound O=C1C(CCCC)C(=O)N(C=2C=CC=CC=2)N1C1=CC=CC=C1 VYMDGNCVAMGZFE-UHFFFAOYSA-N 0.000 description 1
- 229920000137 polyphosphoric acid Polymers 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- YYFIGOPUHPDIBO-UHFFFAOYSA-N propanoic acid;hydrochloride Chemical compound Cl.CCC(O)=O YYFIGOPUHPDIBO-UHFFFAOYSA-N 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 239000004071 soot Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 150000003460 sulfonic acids Chemical class 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/06—Ring systems of three rings
- C07D221/16—Ring systems of three rings containing carbocyclic rings other than six-membered
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Priority Applications (27)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH870171A CH520141A (de) | 1969-05-07 | 1969-05-07 | Verfahren zur Herstellung neuer Indenopyridinderivate |
| CH696769A CH516558A (de) | 1969-05-07 | 1969-05-07 | Verfahren zur Herstellung neuer Indenopyridinderivate |
| CH870271A CH520142A (de) | 1969-05-07 | 1969-05-07 | Verfahren zur Herstellung neuer Indenopyridinderivate |
| CY819A CY819A (en) | 1969-05-07 | 1970-04-10 | Indenopyridine derivatives |
| GB1708070A GB1306404A (en) | 1969-05-07 | 1970-04-10 | Indenopyridine derivatives |
| NL7006274A NL7006274A (cs) | 1969-05-07 | 1970-04-29 | |
| US33498A US3678058A (en) | 1969-05-07 | 1970-04-30 | 1,3,4,9B-TETRAHYDRO-2(2H)-INDENO-{8 1,2-c{9 PYRIDINES |
| FR7016162A FR2051503B1 (cs) | 1969-05-07 | 1970-05-04 | |
| DE19702021747 DE2021747A1 (de) | 1969-05-07 | 1970-05-04 | Verfahren zur Herstellung neuer heterocyclischer Verbindungen |
| NO1707/70A NO132478C (cs) | 1969-05-07 | 1970-05-05 | |
| ES379299A ES379299A1 (es) | 1969-05-07 | 1970-05-05 | Procedimiento para la obtencion de derivados de indenopiri-dina. |
| IE586/70A IE35052B1 (en) | 1969-05-07 | 1970-05-05 | Indenopyridine derivatives |
| SU1839956A SU517256A3 (ru) | 1969-05-07 | 1970-05-05 | Способ получени кислотных солей инденопиридинов |
| PL1970140430A PL80561B1 (cs) | 1969-05-07 | 1970-05-05 | |
| CS3286A CS164267B2 (cs) | 1969-05-07 | 1970-05-05 | |
| SU1435714A SU383293A3 (cs) | 1969-05-07 | 1970-05-05 | |
| CS3110A CS164266B2 (cs) | 1969-05-07 | 1970-05-05 | |
| IL34468A IL34468A (en) | 1969-05-07 | 1970-05-05 | Acidic salt salts of the history of indonopyridine, their preparation and pharmaceutical preparations containing them |
| FI701261A FI51478C (fi) | 1969-05-07 | 1970-05-05 | Menetelmä terapeuttisesti vaikuttavien 1,3,4,9b-tetrahydro-2(2H)-inden o(1,2-c)pyridiinijohdannaisten happoadditiosuolojen valmistamiseksi. |
| SE7006162A SE375310B (cs) | 1969-05-07 | 1970-05-05 | |
| BE749984D BE749984A (fr) | 1969-05-07 | 1970-05-05 | Nouveaux derives de l'indenopyridine, leur preparation et medicaments abase de ces derives |
| CA081,987,A CA951734A (en) | 1969-05-07 | 1970-05-06 | Indenopyridine derivatives |
| ZA703062A ZA703062B (en) | 1969-05-07 | 1970-05-06 | Improvements in or relating to organic compounds |
| AT410570A AT313898B (de) | 1969-05-07 | 1970-05-06 | Verfahren zur Herstellung von Säureadditionssalzen neuer Indenopyridinderivate |
| ES409197A ES409197A1 (es) | 1969-05-07 | 1972-12-01 | Procedimiento para la obtencion de derivados de indenopiri-dina. |
| ES409196A ES409196A1 (es) | 1969-05-07 | 1972-12-01 | Procedimiento para la obtencion de sales de adicion de aci-do de derivados de indenopiridina. |
| MY239/75A MY7500239A (en) | 1969-05-07 | 1975-12-30 | Indenopyridine derivatives |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH696769A CH516558A (de) | 1969-05-07 | 1969-05-07 | Verfahren zur Herstellung neuer Indenopyridinderivate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH516558A true CH516558A (de) | 1971-12-15 |
Family
ID=4317847
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH696769A CH516558A (de) | 1969-05-07 | 1969-05-07 | Verfahren zur Herstellung neuer Indenopyridinderivate |
| CH870171A CH520141A (de) | 1969-05-07 | 1969-05-07 | Verfahren zur Herstellung neuer Indenopyridinderivate |
| CH870271A CH520142A (de) | 1969-05-07 | 1969-05-07 | Verfahren zur Herstellung neuer Indenopyridinderivate |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH870171A CH520141A (de) | 1969-05-07 | 1969-05-07 | Verfahren zur Herstellung neuer Indenopyridinderivate |
| CH870271A CH520142A (de) | 1969-05-07 | 1969-05-07 | Verfahren zur Herstellung neuer Indenopyridinderivate |
Country Status (6)
| Country | Link |
|---|---|
| AT (1) | AT313898B (cs) |
| CH (3) | CH516558A (cs) |
| CS (2) | CS164266B2 (cs) |
| PL (1) | PL80561B1 (cs) |
| SU (2) | SU383293A3 (cs) |
| ZA (1) | ZA703062B (cs) |
-
1969
- 1969-05-07 CH CH696769A patent/CH516558A/de not_active IP Right Cessation
- 1969-05-07 CH CH870171A patent/CH520141A/de not_active IP Right Cessation
- 1969-05-07 CH CH870271A patent/CH520142A/de not_active IP Right Cessation
-
1970
- 1970-05-05 CS CS3110A patent/CS164266B2/cs unknown
- 1970-05-05 PL PL1970140430A patent/PL80561B1/pl unknown
- 1970-05-05 SU SU1435714A patent/SU383293A3/ru active
- 1970-05-05 SU SU1839956A patent/SU517256A3/ru active
- 1970-05-05 CS CS3286A patent/CS164267B2/cs unknown
- 1970-05-06 ZA ZA703062A patent/ZA703062B/xx unknown
- 1970-05-06 AT AT410570A patent/AT313898B/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| SU517256A3 (ru) | 1976-06-05 |
| PL80561B1 (cs) | 1975-08-30 |
| CH520141A (de) | 1972-03-15 |
| CS164266B2 (cs) | 1975-11-07 |
| CH520142A (de) | 1972-03-15 |
| SU383293A3 (cs) | 1973-05-25 |
| AT313898B (de) | 1974-03-11 |
| CS164267B2 (cs) | 1975-11-07 |
| ZA703062B (en) | 1971-12-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE1670480C2 (de) | Pyrido[1,2-a]pyrimidinderivate, Verfahren zu deren Herstellung sowie diese Verbindungen enthaltende pharmazeutische Präparate | |
| DE1795613A1 (de) | Indolylessigsaeuren,Verfahren zu ihrer Herstellung und Arzneipraeparate | |
| CH651563A5 (de) | Hydroxyimino-oktahydro-indolo(2,3-a)chinolizin-derivate sowie verfahren zu ihrer herstellung. | |
| DE2536003C2 (de) | Pyrazol-Derivate, ihre Herstellung und diese enthaltende pharmazeutische Derivate | |
| DE2617955A1 (de) | Neue l-substituierte -aroyl-4-hydroxypiperidine, verfahren zu ihrer herstellung und sie enthaltende arzneimittel | |
| DE2931105C2 (cs) | ||
| DE2021747A1 (de) | Verfahren zur Herstellung neuer heterocyclischer Verbindungen | |
| CH516558A (de) | Verfahren zur Herstellung neuer Indenopyridinderivate | |
| DE3129718C2 (cs) | ||
| DE2404924A1 (de) | Ergolinderivate | |
| AT384221B (de) | Verfahren zur herstellung von neuen 3-substituierten tetrahydro-pyrrolo(1,2-a) pyrimidin-derivaten sowie von deren saeureadditions- und quaternaeren salzen | |
| AT276383B (de) | Verfahren zur Herstellung von neuen Phenylisoindolderivaten und deren Salzen | |
| DE1695617A1 (de) | Verfahren zur Herstellung von neuen Dibenzocycloheptatrienderivaten | |
| DE2136702A1 (cs) | ||
| CH621114A5 (en) | Process for the preparation of 10,11-dihydro-3-carboxy- cyproheptadine and its N-oxide | |
| DE1568253C (de) | N substituierte 1,2 Diphenyl 2 acyloxy 3 amino methyl butene | |
| AT360990B (de) | Verfahren zur herstellung des neuen 1-methyl-4- (3-carboxy-10,11-dihydro-5h-dibenzo-(a,d)- -cyclohepten-5-yliden)-piperidin (10,11-dihydro -3-carboxy-cyproheptadin), seines n-oxids und seiner salze | |
| AT330779B (de) | Verfahren zur herstellung von neuen chinolinessigsaurederivaten und ihren salzen | |
| DE2312256C3 (de) | 5-Pyrazol-essigsäurederivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Mittel | |
| DE1695381B2 (de) | Phthalazino eckige klammer auf 2,3-b eckige klammer zu phthalazine und ein verfahren zu ihrer herstellung | |
| CH532014A (de) | Verfahren zur Herstellung neuer, in Stellung 5 substituierter 5H-Dibenzo(a,d)cycloheptene | |
| DE1295562B (de) | Verfahren zur Herstellung von antiphlogistisch wirksamen, im Acylrest basisch substituierten 1-Phenyl-2, 3-dimethyl-4-acylamino-pyrazolon-(5)-derivaten | |
| CH543506A (de) | Verfahren zur Herstellung neuer Phenylpiperidinderivate | |
| CH543507A (de) | Verfahren zur Herstellung eines neuen Phenylpiperidinderivates | |
| DE2813895A1 (de) | Neue 2,4,6-trisubstituierte 2,3- dihydrobenzofuranderivate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased |